Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Vij

Showing results (231-240 of 283) with videos related to

Pageof 29
Sort By:
Blood|October 27, 2012
Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemiaChristopher J Hickey, Sebastian Schwind, Hanna S Radomska, et al.
Blood|March 13, 2012
Reduced intensity conditioning is superior to nonmyeloablative conditioning for older chronic myelogenous leukemia patients undergoing hematopoietic cell transplant during the tyrosine kinase inhibitor eraErica Warlick, Kwang Woo Ahn, Tanya L Pedersen, et al.
Blood|June 22, 2011
Trends in allogeneic stem cell transplantation for multiple myeloma: a CIBMTR analysisShaji Kumar, Mei-Jie Zhang, Peigang Li, et al.
Blood|July 2, 2015
Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemiaStefan O Ciurea, Mei-Jie Zhang, Andrea A Bacigalupo, et al.
JCO Precision Oncology|May 26, 2021
Impact of a 40-Gene Targeted Panel Test on Physician Decision Making for Patients With Acute Myeloid LeukemiaErica K Barnell, Kenneth F Newcomer, Zachary L Skidmore, et al.
Leukemia|March 13, 2019
Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapyUjjawal H Gandhi, Robert F Cornell, Arjun Lakshman, et al.
Blood Advances|October 17, 2022
Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myelomaErica K Barnell, Zachary L Skidmore, Kenneth F Newcomer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 12, 2025
Memory-like NK cell differentiation, inhibitory NKG2A blockade, and improved recognition via antibody or CAR engineering combine to enhance NK cell attack against multiple myelomaAlice Y Zhou, Nancy D Marin, Sadia Afrin, et al.
JCO Oncology Practice|May 30, 2020
Variability in Cytogenetic Testing for Multiple Myeloma: A Comprehensive Analysis From Across the United StatesYang Yu, Niquelle Brown Wade, Amie E Hwang, et al.
Leukemia & Lymphoma|July 3, 2018
Secondary plasma cell leukemia: a multicenter retrospective study of 101 patientsArtur Jurczyszyn, Jorge J Castillo, Irit Avivi, et al.
Pageof 29

Showing results (231-240 of 283) with videos related to

Sort By:
Pageof 29
Blood|October 27, 2012
Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemiaChristopher J Hickey, Sebastian Schwind, Hanna S Radomska, et al.
Blood|March 13, 2012
Reduced intensity conditioning is superior to nonmyeloablative conditioning for older chronic myelogenous leukemia patients undergoing hematopoietic cell transplant during the tyrosine kinase inhibitor eraErica Warlick, Kwang Woo Ahn, Tanya L Pedersen, et al.
Blood|June 22, 2011
Trends in allogeneic stem cell transplantation for multiple myeloma: a CIBMTR analysisShaji Kumar, Mei-Jie Zhang, Peigang Li, et al.
Blood|July 2, 2015
Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemiaStefan O Ciurea, Mei-Jie Zhang, Andrea A Bacigalupo, et al.
JCO Precision Oncology|May 26, 2021
Impact of a 40-Gene Targeted Panel Test on Physician Decision Making for Patients With Acute Myeloid LeukemiaErica K Barnell, Kenneth F Newcomer, Zachary L Skidmore, et al.
Leukemia|March 13, 2019
Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapyUjjawal H Gandhi, Robert F Cornell, Arjun Lakshman, et al.
Blood Advances|October 17, 2022
Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myelomaErica K Barnell, Zachary L Skidmore, Kenneth F Newcomer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 12, 2025
Memory-like NK cell differentiation, inhibitory NKG2A blockade, and improved recognition via antibody or CAR engineering combine to enhance NK cell attack against multiple myelomaAlice Y Zhou, Nancy D Marin, Sadia Afrin, et al.
JCO Oncology Practice|May 30, 2020
Variability in Cytogenetic Testing for Multiple Myeloma: A Comprehensive Analysis From Across the United StatesYang Yu, Niquelle Brown Wade, Amie E Hwang, et al.
Leukemia & Lymphoma|July 3, 2018
Secondary plasma cell leukemia: a multicenter retrospective study of 101 patientsArtur Jurczyszyn, Jorge J Castillo, Irit Avivi, et al.
Pageof 29